openPR Logo

Press Releases from greenovation Biotech GmbH (4 total)

greenovation increases investment in GMP-compliant process development for produ …

The primary objective of the investment is the implementation of a stable production platform for the manufacture of glycoproteins for industrial pharmaceutical applications, in accordance with GMP (Good Manufacturing Practice) guidelines - Gregor Mirow succeeds Hans Bodo Hartmann as the new managing director of greenovation Biotech GmbH Heilbronn, Germany – August 28th, 2008 – greenovation Biotech GmbH is investing in an accelerated implementation of its technical production platform in order

greenovation launches Bryo-Speed™ and Bryo-Master™ for the production of the …

From pilot study to stable production: in Bryo-Speed™ and Bryo-Master™ greenovation presents a production platform for custom-made pharmaceuticals – Presentation of the new products at BioProduction 2007 in Berlin Heilbronn/ Germany – November 1st 2007 – greenovation.com. Bryo-Speed™ and Bryo-Master™ are greenovation’s innovative production systems for the effective optimization and creation of pharmaceutically highly efficient glycoproteins: The production platform is based on bryotechnology which has been developed by greenovation

Joint process development between Sartorius Stedim Biotech and greenovation Biot …

greenovation.com - Major step taken towards process-scale implementation of proprietary bryotechnology developed by greenovation - In demand - Sartorius expertise in fermentation and purification process engineering Heilbronn/ Göttingen – Oktober 12, 2007. Sartorius Stedim Biotech GmbH, headquartered in Goettingen, and greenovation Biotech GmbH in Heilbronn, Germany, agreed to collaborate on the project of process-scale implementation of the innovative, plant-based bryotechnology developed by greenovation. In the past years, greenovation Biotech and Sartorius Stedim

greenovation Biotech GmbH gets first US Patent Granted on Glyco-Engineering Port …

greenovation Biotech GmbH announces the granting of their first US patent in the area of plant-based glyco-engineering. This patent offers wide-ranging protection for the targeted processing of a plant-specific sugar residue. First Patent from a Complete Patent Family Heilbronn – June 20, 2007. Scientists at greenovation Biotech GmbH have been able to build on many years of experience in the area of the design of production strains in moss, in their work